The Cigna Group
CI
$337.41
-$7.09-2.06%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 12.06% | 7.75% | 5.99% | 4.77% | -0.36% |
| Total Other Revenue | 5.13% | 20.29% | 24.94% | 35.99% | 5.84% |
| Total Revenue | 11.63% | 8.48% | 7.10% | 6.36% | 0.01% |
| Cost of Revenue | 11.18% | 7.69% | 7.97% | 6.35% | 0.18% |
| Gross Profit | 14.80% | 14.05% | 1.47% | 6.38% | -1.21% |
| SG&A Expenses | 9.21% | 14.03% | 5.78% | 9.60% | 2.00% |
| Depreciation & Amortization | -1.31% | -1.30% | -9.18% | 0.22% | -8.42% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.89% | 8.05% | 7.60% | 6.54% | 0.23% |
| Operating Income | 30.01% | 17.51% | -2.31% | 2.37% | -5.16% |
| Income Before Tax | -86.16% | -47.29% | -4.90% | 2.17% | 3.51% |
| Income Tax Expenses | -775.74% | -45.16% | -9.00% | -16.90% | -24.02% |
| Earnings from Continuing Operations | -9.41% | -47.84% | -3.82% | 7.76% | 7.86% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -168.97% | -95.24% | -284.62% | -160.00% | -70.59% |
| Net Income | -13.75% | -48.93% | -6.23% | 5.85% | 6.90% |
| EBIT | 30.01% | 17.51% | -2.31% | 2.37% | -5.16% |
| EBITDA | 22.38% | 14.39% | -1.87% | 2.94% | -4.00% |
| EPS Basic | -10.57% | -47.23% | 0.33% | 14.00% | 15.38% |
| Normalized Basic EPS | 33.93% | 18.89% | -2.69% | 3.96% | -2.85% |
| EPS Diluted | -10.53% | -47.16% | 0.61% | 13.67% | 15.27% |
| Normalized Diluted EPS | 33.93% | 19.08% | -2.49% | 3.72% | -2.85% |
| Average Basic Shares Outstanding | -3.55% | -3.22% | -6.54% | -7.15% | -7.35% |
| Average Diluted Shares Outstanding | -3.55% | -3.38% | -6.73% | -6.94% | -7.35% |
| Dividend Per Share | 9.82% | 9.82% | 9.82% | 9.82% | 12.00% |
| Payout Ratio | 0.24% | 1.08% | 0.10% | -0.03% | -0.04% |
